{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:13:52Z","timestamp":1789038832014,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Healthcare Project Fund of the Department of Logistics Support","award":["21BJZ50"],"award-info":[{"award-number":["21BJZ50"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04695-7","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:32:17Z","timestamp":1760455937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic evaluation of iPSC-derived CD146+\u2009mesenchymal stem cells in ulcerative colitis: biological properties and potential mechanisms"],"prefix":"10.1186","volume":"16","author":[{"given":"Lv","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingru","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"9853","key":"4695_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606\u201319.","journal-title":"Lancet"},{"issue":"21","key":"4695_CR2","doi-asserted-by":"publisher","first-page":"11365","DOI":"10.3390\/ijms222111365","volume":"22","author":"J Popov","year":"2021","unstructured":"Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int J Mol Sci. 2021;22(21):11365.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4695_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S2468-1253(19)30358-9","volume":"5","author":"V Jairath","year":"2020","unstructured":"Jairath V, Feagan BG. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2\u20133.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"4695_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643\u201354.","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"4695_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"4695_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Reviews Gastroenterol Hepatol. 2015;12(12):720\u20137.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"10114","key":"4695_CR7","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378.","journal-title":"Lancet"},{"issue":"27","key":"4695_CR8","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"4695_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"5411","key":"4695_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137.","journal-title":"Science"},{"issue":"2","key":"4695_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","volume":"24","author":"JK Biehl","year":"2009","unstructured":"Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98\u2013103. (quiz 4\u20135).","journal-title":"J Cardiovasc Nurs"},{"issue":"15","key":"4695_CR12","doi-asserted-by":"publisher","first-page":"8494","DOI":"10.3390\/ijms23158494","volume":"23","author":"HM Zhang","year":"2022","unstructured":"Zhang HM, Yuan S, Meng H, Hou XT, Li J, Xue JC, et al. Stem cell-based therapies for inflammatory bowel disease. Int J Mol Sci. 2022;23(15):8494.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4695_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biom11010082","volume":"11","author":"JZ Ko","year":"2021","unstructured":"Ko JZ, Johnson S, Dave M. Efficacy and safety of mesenchymal stem\/stromal cell therapy for inflammatory bowel diseases: an up-to-date systematic review. Biomolecules. 2021;11(1):82.","journal-title":"Biomolecules"},{"key":"4695_CR14","doi-asserted-by":"publisher","first-page":"106891","DOI":"10.1016\/j.phrs.2023.106891","volume":"195","author":"L Hidalgo-Garc\u00eda","year":"2023","unstructured":"Hidalgo-Garc\u00eda L, Ruiz-Malagon AJ, Huertas F, Rodr\u00edguez-Sojo MJ, Molina-Tijeras JA, Diez-Echave P, et al. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL\/6J mice modulating the immune response and gut dysbiosis. Pharmacol Res. 2023;195:106891.","journal-title":"Pharmacol Res"},{"issue":"2","key":"4695_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00018-020-03600-0","volume":"78","author":"LA Costa","year":"2021","unstructured":"Costa LA, Eiro N, Fraile M, Gonzalez LO, Sa\u00e1 J, Garcia-Portabella P, et al. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses. Cell Mol Life Sci. 2021;78(2):447\u201367.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"4695_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/jcmm.12839","volume":"20","author":"V Sabapathy","year":"2016","unstructured":"Sabapathy V, Kumar S. hiPSC-derived iMSCs: nextgen MSCs as an advanced therapeutically active cell resource for regenerative medicine. J Cell Mol Med. 2016;20(8):1571\u201388.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4695_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13287-015-0137-7","volume":"6","author":"R Kang","year":"2015","unstructured":"Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6(1):144.","journal-title":"Stem Cell Res Ther"},{"key":"4695_CR18","doi-asserted-by":"publisher","first-page":"9601623","DOI":"10.1155\/2018\/9601623","volume":"2018","author":"C Zhao","year":"2018","unstructured":"Zhao C, Ikeya M. Generation and applications of induced pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Int. 2018;2018:9601623.","journal-title":"Stem Cells Int"},{"issue":"6","key":"4695_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/sctm.17-0305","volume":"7","author":"S Soontararak","year":"2018","unstructured":"Soontararak S, Chow L, Johnson V, Coy J, Wheat W, Regan D, et al. Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and Microbiome normalization in mouse inflammatory bowel disease model. Stem Cells Transl Med. 2018;7(6):456\u201367.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4695_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13287-017-0510-9","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Wang Y, Zhao B, Niu X, Hu B, Li Q, et al. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res Ther. 2017;8(1):64.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4695_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.stemcr.2014.07.003","volume":"3","author":"J Frobel","year":"2014","unstructured":"Frobel J, Hemeda H, Lenz M, Abagnale G, Joussen S, Denecke B, et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep. 2014;3(3):414\u201322.","journal-title":"Stem Cell Rep"},{"issue":"12","key":"4695_CR22","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1182\/blood-2010-12-325324","volume":"118","author":"M Giuliani","year":"2011","unstructured":"Giuliani M, Oudrhiri N, Noman ZM, Vernochet A, Chouaib S, Azzarone B, et al. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood. 2011;118(12):3254\u201362.","journal-title":"Blood"},{"issue":"12","key":"4695_CR23","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/jcb.25596","volume":"117","author":"J Ng","year":"2016","unstructured":"Ng J, Hynes K, White G, Sivanathan KN, Vandyke K, Bartold PM, et al. Immunomodulatory properties of induced pluripotent stem cell-derived mesenchymal cells. J Cell Biochem. 2016;117(12):2844\u201353.","journal-title":"J Cell Biochem"},{"key":"4695_CR24","doi-asserted-by":"publisher","first-page":"8867349","DOI":"10.1155\/2020\/8867349","volume":"2020","author":"YH Chang","year":"2020","unstructured":"Chang YH, Wu KC, Ding DC. Induced pluripotent stem cell-differentiated chondrocytes repair cartilage defect in a rabbit osteoarthritis model. Stem Cells Int. 2020;2020:8867349.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4695_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00281-018-0721-x","volume":"41","author":"ML Saetersmoen","year":"2019","unstructured":"Saetersmoen ML, Hammer Q, Valamehr B, Kaufman DS, Malmberg KJ. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Semin Immunopathol. 2019;41(1):59\u201368.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"4695_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/jcmm.12168","volume":"18","author":"N Espagnolle","year":"2014","unstructured":"Espagnolle N, Guilloton F, Deschaseaux F, Gadelorge M, Sens\u00e9b\u00e9 L, Bourin P. CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med. 2014;18(1):104\u201314.","journal-title":"J Cell Mol Med"},{"key":"4695_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-015-0266-z","volume":"7","author":"L Harkness","year":"2016","unstructured":"Harkness L, Zaher W, Ditzel N, Isa A, Kassem M. CD146\/MCAM defines functionality of human bone marrow stromal stem cell populations. Stem Cell Res Ther. 2016;7:4.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"4695_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.joca.2019.04.002","volume":"27","author":"S Wangler","year":"2019","unstructured":"Wangler S, Menzel U, Li Z, Ma J, Hoppe S, Benneker LM, et al. CD146\/MCAM distinguishes stem cell subpopulations with distinct migration and regenerative potential in degenerative intervertebral discs. Osteoarthritis Cartilage. 2019;27(7):1094\u2013105.","journal-title":"Osteoarthritis Cartilage"},{"issue":"24","key":"4695_CR29","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1073\/pnas.86.24.9891","volume":"86","author":"JM Lehmann","year":"1989","unstructured":"Lehmann JM, Riethm\u00fcller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the Immunoglobulin superfamily. Proc Natl Acad Sci U S A. 1989;86(24):9891\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"68","key":"4695_CR30","doi-asserted-by":"publisher","first-page":"112283","DOI":"10.18632\/oncotarget.22736","volume":"8","author":"M Nollet","year":"2017","unstructured":"Nollet M, Stalin J, Moyon A, Traboulsi W, Essaadi A, Robert S, et al. A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule. Oncotarget. 2017;8(68):112283\u201396.","journal-title":"Oncotarget"},{"issue":"1","key":"4695_CR31","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/s41598-017-01061-3","volume":"7","author":"P Zeng","year":"2017","unstructured":"Zeng P, Li H, Lu PH, Zhou LN, Tang M, Liu CY, et al. Prognostic value of CD146 in solid tumor: a systematic review and meta-analysis. Sci Rep. 2017;7(1):4223.","journal-title":"Sci Rep"},{"issue":"6","key":"4695_CR32","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ijc.32909","volume":"147","author":"J Stalin","year":"2020","unstructured":"Stalin J, Traboulsi W, Vivancos-Stalin L, Nollet M, Joshkon A, Bachelier R, et al. Therapeutic targeting of soluble CD146\/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors. Int J Cancer. 2020;147(6):1666\u201379.","journal-title":"Int J Cancer"},{"issue":"8","key":"4695_CR33","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1182\/blood-2005-06-2307","volume":"106","author":"MF Elshal","year":"2005","unstructured":"Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood. 2005;106(8):2923\u20134.","journal-title":"Blood"},{"issue":"1","key":"4695_CR34","doi-asserted-by":"publisher","first-page":"17721","DOI":"10.1038\/s41598-019-54132-y","volume":"9","author":"A Gabsi","year":"2019","unstructured":"Gabsi A, Heim X, Dlala A, Gati A, Sakhri H, Abidi A, et al. TH17 cells expressing CD146 are significantly increased in patients with systemic sclerosis. Sci Rep. 2019;9(1):17721.","journal-title":"Sci Rep"},{"issue":"5","key":"4695_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.exphem.2007.12.015","volume":"36","author":"DT Covas","year":"2008","unstructured":"Covas DT, Panepucci RA, Fontes AM, Silva WA Jr., Orellana MD, Freitas MC, et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146\u2009+\u2009perivascular cells and fibroblasts. Exp Hematol. 2008;36(5):642\u201354.","journal-title":"Exp Hematol"},{"issue":"10","key":"4695_CR36","doi-asserted-by":"publisher","first-page":"e76153","DOI":"10.1371\/journal.pone.0076153","volume":"8","author":"WP Tsang","year":"2013","unstructured":"Tsang WP, Shu Y, Kwok PL, Zhang F, Lee KK, Tang MK, et al. CD146\u2009+\u2009human umbilical cord perivascular cells maintain stemness under hypoxia and as a cell source for skeletal regeneration. PLoS ONE. 2013;8(10):e76153.","journal-title":"PLoS ONE"},{"key":"4695_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13287-016-0285-4","volume":"7","author":"CC Wu","year":"2016","unstructured":"Wu CC, Liu FL, Sytwu HK, Tsai CY, Chang DM. CD146\u2009+\u2009mesenchymal stem cells display greater therapeutic potential than CD146-cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther. 2016;7:23.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4695_CR38","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.3892\/mmr.2017.7616","volume":"16","author":"YX Wu","year":"2017","unstructured":"Wu YX, Jing XZ, Sun Y, Ye YP, Guo JC, Huang JM, et al. CD146\u2009+\u2009skeletal stem cells from growth plate exhibit specific chondrogenic differentiation capacity in vitro. Mol Med Rep. 2017;16(6):8019\u201328.","journal-title":"Mol Med Rep"},{"issue":"3","key":"4695_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14728222.2021.1901079","volume":"25","author":"Y Du","year":"2021","unstructured":"Du Y, Rong L, Cong Y, Shen L, Zhang N, Wang B. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opin Ther Targets. 2021;25(3):191\u2013209.","journal-title":"Expert Opin Ther Targets"},{"key":"4695_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/JIR.S396088","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang X, Liu Y, Zhang W, Wu C-T, Wang L. CD146\u2009+\u2009umbilical cord mesenchymal stem cells exhibit high Immunomodulatory activity and therapeutic efficacy in septic mice. J Inflamm Res. 2023;16:579\u201394.","journal-title":"J Inflamm Res"},{"issue":"8","key":"4695_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/stem.3196","volume":"38","author":"AC Bowles","year":"2020","unstructured":"Bowles AC, Kouroupis D, Willman MA, Perucca Orfei C, Agarwal A, Correa D. Signature quality attributes of CD146+\u2009mesenchymal stem\/stromal cells correlate with high therapeutic and secretory potency. Stem Cells. 2020;38(8):1034\u201349.","journal-title":"Stem Cells"},{"issue":"1","key":"4695_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13287-022-02916-x","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Sun Y, Zhang X-X, Liu Y-B, Sun H-Y, Wu C-T, et al. Comparison of CD146 +\/- mesenchymal stem cells in improving premature ovarian failure. Stem Cell Res Ther. 2022;13(1):267.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"4695_CR43","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295\u2013309.","journal-title":"Nat Protoc"},{"issue":"18","key":"4695_CR44","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.1111\/jcmm.16851","volume":"25","author":"S Rajasingh","year":"2021","unstructured":"Rajasingh S, Sigamani V, Selvam V, Gurusamy N, Kirankumar S, Vasanthan J, et al. Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells. J Cell Mol Med. 2021;25(18):8904\u201319.","journal-title":"J Cell Mol Med"},{"issue":"19","key":"4695_CR45","doi-asserted-by":"publisher","first-page":"10394","DOI":"10.3390\/ijms251910394","volume":"25","author":"P Wang","year":"2024","unstructured":"Wang P, Zhang Y, Li Z, Zhou S, Tang Q, Wang Z, et al. Mesenchymal stem cells derived from human urine-derived iPSCs exhibit low immunogenicity and reduced Immunomodulatory profile. Int J Mol Sci. 2024;25(19):10394.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4695_CR46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","volume":"121","author":"Q Lian","year":"2010","unstructured":"Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121(9):1113\u201323.","journal-title":"Circulation"},{"issue":"1","key":"4695_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/mt.2012.207","volume":"21","author":"K Shao","year":"2013","unstructured":"Shao K, Koch C, Gupta MK, Lin Q, Lenz M, Laufs S, et al. Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Mol Ther. 2013;21(1):240\u201350.","journal-title":"Mol Ther"},{"issue":"7","key":"4695_CR48","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey E, Anderson P, Gonz\u00e1lez MA, Rico L, B\u00fcscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58(7):929\u201339.","journal-title":"Gut"},{"issue":"8","key":"4695_CR49","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s10067-022-06202-2","volume":"41","author":"DP Misra","year":"2022","unstructured":"Misra DP, Agarwal V. Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases. Clin Rheumatol. 2022;41(8):2297\u2013308.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4695_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","volume":"160","author":"C Johansen","year":"2009","unstructured":"Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009;160(2):319\u201324.","journal-title":"Br J Dermatol"},{"issue":"92","key":"4695_CR51","doi-asserted-by":"publisher","first-page":"ra63","DOI":"10.1126\/scisignal.2000382","volume":"2","author":"C Liu","year":"2009","unstructured":"Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal. 2009;2(92):ra63.","journal-title":"Sci Signal"},{"issue":"5","key":"4695_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the Yin and the Yang. Trends Immunol. 2017;38(5):310\u201322.","journal-title":"Trends Immunol"},{"issue":"1","key":"4695_CR53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu L, Li R, Huang Y, Wang S. The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8(1):402.","journal-title":"Signal Transduct Target Ther"},{"key":"4695_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2020.00235","volume":"11","author":"Z Qin","year":"2020","unstructured":"Qin Z, Wang PY, Wan JJ, Zhang Y, Wei J, Sun Y, et al. MicroRNA124-IL6R mediates the effect of nicotine in inflammatory bowel disease by shifting Th1\/Th2 balance toward Th1. Front Immunol. 2020;11:235.","journal-title":"Front Immunol"},{"issue":"7","key":"4695_CR55","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/cells9071660","volume":"9","author":"C Terraza-Aguirre","year":"2020","unstructured":"Terraza-Aguirre C, Campos-Mora M, Elizondo-Vega R, Contreras-L\u00f3pez RA, Luz-Crawford P, Jorgensen C, et al. Mechanisms behind the immunoregulatory dialogue between mesenchymal stem cells and Th17 cells. Cells. 2020;9(7):1660.","journal-title":"Cells"},{"issue":"1","key":"4695_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13287-023-03365-w","volume":"14","author":"C Hua","year":"2023","unstructured":"Hua C, Liang Q, Chen S, Zhu J, Tang Y, Chen X, et al. Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model. Stem Cell Res Ther. 2023;14(1):147.","journal-title":"Stem Cell Res Ther"},{"key":"4695_CR57","doi-asserted-by":"publisher","first-page":"926915","DOI":"10.3389\/fmicb.2022.926915","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Lin X, Wang W, Wang W, Cheng S, Huang Y, et al. The Proinflammatory role of guanylate-binding protein 5 in inflammatory bowel diseases. Front Microbiol. 2022;13:926915.","journal-title":"Front Microbiol"},{"key":"4695_CR58","doi-asserted-by":"publisher","first-page":"7040113","DOI":"10.1155\/2023\/7040113","volume":"2023","author":"Y Ning","year":"2023","unstructured":"Ning Y, Lin K, Fang J, Chen X, Hu X, Liu L, et al. Pyroptosis-related signature predicts the progression of ulcerative colitis and colitis-associated colorectal cancer as well as the anti-TNF therapeutic response. J Immunol Res. 2023;2023:7040113.","journal-title":"J Immunol Res"},{"issue":"2","key":"4695_CR59","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.1701322","volume":"201","author":"A Napolitano","year":"2018","unstructured":"Napolitano A, van der Veen AG, Bunyan M, Borg A, Frith D, Howell S, et al. Cysteine-reactive free ISG15 generates IL-1\u03b2-producing CD8\u03b1(+) DENDRITIC CELLS AT THE SITE OF infection. J Immunol. 2018;201(2):604\u201314.","journal-title":"J Immunol"},{"issue":"suppl2","key":"4695_CR60","doi-asserted-by":"publisher","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","volume":"12","author":"PJ Trivedi","year":"2018","unstructured":"Trivedi PJ, Adams DH. Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise. J Crohns Colitis. 2018;12(suppl2):S641\u201352.","journal-title":"J Crohns Colitis"},{"key":"4695_CR61","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.intimp.2019.04.020","volume":"72","author":"L Cao","year":"2019","unstructured":"Cao L, Xu H, Wang G, Liu M, Tian D, Yuan Z. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72:264\u201374.","journal-title":"Int Immunopharmacol"},{"key":"4695_CR62","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.rvsc.2019.06.012","volume":"125","author":"WJ Song","year":"2019","unstructured":"Song WJ, Li Q, Ryu MO, Nam A, An JH, Jung YC, et al. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance Immunomodulatory effects in inflammatory bowel disease in mice. Res Vet Sci. 2019;125:176\u201384.","journal-title":"Res Vet Sci"},{"key":"4695_CR63","doi-asserted-by":"publisher","first-page":"604021","DOI":"10.3389\/fcell.2020.604021","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Ma K, Zhang L, Xu H, Zhang N. Human umbilical cord blood derived-mesenchymal stem cells alleviate dextran sulfate sodium-induced colitis by increasing regulatory T cells in mice. Front Cell Dev Biol. 2020;8:604021.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"4695_CR64","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.7150\/thno.45434","volume":"10","author":"X Cao","year":"2020","unstructured":"Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, et al. IGF-1\u00a0C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE(2)-mediated M2 macrophage polarization. Theranostics. 2020;10(17):7697\u2013709.","journal-title":"Theranostics"},{"key":"4695_CR65","doi-asserted-by":"publisher","first-page":"795048","DOI":"10.3389\/fimmu.2021.795048","volume":"12","author":"L Ou","year":"2021","unstructured":"Ou L, Zhang A, Cheng Y, Chen Y. The cGAS-STING pathway: a promising immunotherapy target. Front Immunol. 2021;12:795048.","journal-title":"Front Immunol"},{"issue":"2","key":"4695_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/21645515.2017.1395995","volume":"14","author":"T Ohkuri","year":"2018","unstructured":"Ohkuri T, Kosaka A, Nagato T, Kobayashi H. Effects of STING stimulation on macrophages: STING agonists polarize into classically or alternatively activated macrophages? Hum Vaccin Immunother. 2018;14(2):285\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"4695_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40425-019-0573-5","volume":"7","author":"W Jing","year":"2019","unstructured":"Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J, et al. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. J Immunother Cancer. 2019;7(1):115.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"4695_CR68","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.2200351","volume":"210","author":"X Shen","year":"2023","unstructured":"Shen X, Sun C, Cheng Y, Ma D, Sun Y, Lin Y, et al. cGAS mediates inflammation by polarizing macrophages to M1 phenotype via the mTORC1 pathway. J Immunol. 2023;210(8):1098\u2013107.","journal-title":"J Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04695-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04695-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:05:08Z","timestamp":1760457908000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04695-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4695"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04695-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical Ethics declaration: (1) Title of the approved project: Postpartum Umbilical Cord Collection. (2) Name of the institutional approval committee or unit: Medical Ethics Committee of Beijing Shangdi Hospital. (3) Approval number: SDEC-KT-\u20092023-2-S02. (4) Date of approval: 2023.05.16. This research has obtained relevant ethics approval, and the patient or his\/her guardian\/legally authorized representative\/next of kin has provided written informed consent for participating in the research and\/or using samples. For human iMSCs, Nuwacell Ltd. has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. Animal Ethics declaration: (1) Title of the approved project: Biological characteristics of iPSC-derived CD146+ mesenchymal stem cells and efficacy and mechanism of treatment of ulcerative colitis. (2) Name of the institutional approval committee or unit: Ethics Committee of the Laboratory Animal Centre of the Academy of Military Medical Sciences. (3) Approval number: IACUC-DWZX-2023-571. (4) Date of approval: November 29, 2023. The protocols for animal experiments adhere to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}